NEW YORK, Feb. 3, 2014 /PRNewswire/ -- BNY Mellon, a
global leader in investment management and investment services, has
been appointed by Chr. Hansen as depositary bank for its sponsored
American depositary receipt (ADR) program. Previously, the company
traded in the U.S. over-the-counter (OTC) market as an unsponsored
DR. Each Chr. Hansen ADR represents one-half of an ordinary
share and trades OTC under the symbol "CHYHY." Chr. Hansen's
ordinary shares trade on the NASDAQ OMX under the symbol "CHR."
Founded in 1874, Chr. Hansen is a global bioscience company that
develops natural ingredient solutions for the food, nutritional,
pharmaceutical and agricultural industries. Products include
cultures, enzymes, probiotics and natural colors. All solutions are
based on strong research and development competencies, coupled with
significant technology investments. The company has more than 2,500
employees in 30 countries and main production facilities in
Denmark, France, the U.S. and Germany.
"Chr. Hansen has been in the U.S. for more than 100 years,
primarily serving the dairy markets," said Klaus Pedersen, CFO of Chr. Hansen Holding A/S.
"Following our IPO in 2010, we have seen increasing interest from
U.S.-based investors. With this sponsored ADR program we show our
commitment to this market by providing a convenient way to invest
in Chr. Hansen."
"We look forward to supporting Chr. Hansen and enhancing their
access to American investors," said Christopher M. Kearns, CEO of BNY Mellon's
Depositary Receipts business. "We'll work closely with the
company's management team on a customized outreach program to help
them realize the added benefits of this new sponsored ADR."
BNY Mellon acts as depositary for more than 2,700 American and
global depositary receipt programs, acting in partnership with
leading companies from 68 countries. BNY Mellon is committed to
helping securities issuers access the world's rapidly evolving
financial markets and delivers a comprehensive suite of depositary
receipt services. Learn more at www.bnymellon.com/dr.
BNY Mellon is a global investments company dedicated to helping
its clients manage and service their financial assets throughout
the investment lifecycle. Whether providing financial services for
institutions, corporations or individual investors, BNY Mellon
delivers informed investment management and investment services in
35 countries and more than 100 markets. As of Dec. 31, 2013, BNY Mellon had $27.6 trillion in assets under custody and/or
administration, and $1.6 trillion in
assets under management. BNY Mellon can act as a single point of
contact for clients looking to create, trade, hold, manage,
service, distribute or restructure investments. BNY Mellon is the
corporate brand of The Bank of New York Mellon Corporation (NYSE:
BK). Learn more at www.bnymellon.com, or follow us on Twitter
@BNYMellon.
This release is for informational purposes only. BNY Mellon
provides no advice nor recommendation or endorsement with respect
to any company or securities. Nothing herein shall be deemed to
constitute an offer to sell or a solicitation of an offer to buy
securities. Depositary Receipts: Not FDIC, State or Federal Agency
Insured; May Lose Value; No Bank, State or Federal Agency
Guarantee. BNY Mellon provides no advice nor recommendations or
endorsement with respect to any company, security or products based
on any index licensed by BNY Mellon, and we make no representation
regarding the advisability of investing in the same.
|
|
|
|
|
Contact:
|
|
Joseph F. Ailinger
Jr.
|
|
Dori
Flanagan
|
|
|
+1
617-722-7571
|
|
+1
212-815-2291
|
|
|
joe.ailinger@bnymellon.com
|
|
dori.flanagan@bnymellon.com
|
|
|
|
|
|
SOURCE BNY Mellon